Ilene Gewirtz, MD, discusses her comprehensive approach to well visits and cancer screens and says education, if not expanded services, is key.
Even brief use of hormone replacement therapy in menopause can increase risk of the 2 most common forms of ovarian cancer, a meta-analysis finds.
Treatments to remove precancerous cervical lesions don't seem to affect a woman's ability to become pregnant, new research found.
Women in routine gynecologic care expressed willingness to extend screening intervals and use cytology alone or Pap-HPV cotesting if recommended by a physician.
Despite achieving complete surgical resection, advanced epithelial ovarian cancer or primary peritoneal cancer patients with a high disease burden had worse survival outcomes than those with lower disease burden.
Conservative management of cervical intraepithelial neoplasia (CIN) grade 2 is an appropriate treatment option for women aged 25 years and younger.
Drinking coffee multiple times a day may decrease the risk of endometrial cancer in women, according to a new study.
Could the approval of bevacizumab for advanced cervical cancer and platinum-resistant ovarian cancer last year lead to patient-specific therapies?
A test for dangerous strains of high-risk HPV using messenger RNA was shown to be reliable and effective for cervical cancer risk stratification.
Adding the PARP inhibitor veliparib to cyclophosphamide did not improve response rates or progression-free survival in ovarian cancer.